Cardiac Bio Implant Devices Market Forecast and Company Analysis 2024-2032 Featuring F. Hoffman-La Roche, Eurofins Scientific, Illumina, Natera, Abbott, Thermo Fisher Scientific, Quest, and Agilent
September 24, 2024 04:03 ET
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Bio Implant Devices Market Global Forecast Report By Type, Application, End-User, Countries and Company Analysis 2024-2032" report has been...
Bio-Implants - A $223 Billion Global Market Opportunity by 2031 with LifeNet Health, Smith & Nephew, Arthrex, Clinic Lemanic, and Alpha Bio Tec Dominating the Competition
May 10, 2024 09:27 ET
|
Research and Markets
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Bio-Implants Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Material,...
Cardiac Bio Implant Devices Market, Size and Global Forecast 2023-2030 - A $60.20 Billion Market Opportunity by 2030
December 18, 2023 04:13 ET
|
Research and Markets
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Global Cardiac Bio Implant Devices Market Report 2022 Featuring Agilent, Eurofins Scientific, F. Hoffman-La Roche, Illumina,, Natera, PerkinElmer, Quest Diagnostics, Thermo Fisher Scientific
May 04, 2022 04:33 ET
|
Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Global Cardiac Bio Implant Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis" report has...